Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
NCT07269106Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hsk21542 in postoperative pain, sponsored by Zhongshan Ophthalmic Center. Started Jan 2026; status: recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07269106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07269106.